CClinicalTrials.gg
RecruitingNCT07586592Updated May 14, 2026

Comparison of Age-Based Formula and Ultrasound-Guided Subglottic Diameter Measurement for Endotracheal Tube Sizing

An interventional study of Ultrasound and Cole's Formula in Endotracheal Tube Wrongly Placed During Anesthetic Procedure, sponsored by Ain Shams University. Recruiting at 1 site in Egypt. Open to participants aged 3 Months to 8 Years. Per ClinicalTrials.gov, last updated 2026-05-14.

Sponsored by Ain Shams University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jan 2026, registered Apr 2026).
  • Started Jan 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
3 Months to 8 Years
Sex
All
01

Study summary

To compare the accuracy of ultrasound-guided subglottic diameter measurement versus age-based formulas in determining the optimal endotracheal tube (ETT) size in pediatric patients with single ventricle physiology and reducing post-extubation complications.

Read the detailed description

To compare the accuracy of ultrasound-guided subglottic diameter measurement versus age-based formulas in determining optimal ETT size in pediatric patients with single ventricle physiology to avoid post-extubation complications. All legal guardians will provide written informed consent after a full explanation of the study. During the pre-anesthetic evaluation, demographic data, ASA physical status, relevant comorbidities, and a recent echocardiogram confirming single ventricle physiology will be documented. In the operating room, patients will be monitored using standard ASA monitors including ECG, non-invasive blood pressure, pulse oximetry, and capnography, followed by preoxygenation with 100% oxygen. If intravenous access is available, anesthesia will be induced with ketamine, fentanyl, and rocuronium. If IV access is not available, inhalational induction with sevoflurane will be used until IV access is secured, after which fentanyl and rocuronium will be administered. Following induction, ventilation will continue with FiO₂ 100% and sevoflurane 1.5% for 3 minutes.

Patients will be divided into two groups:

Group A (Age-Based Formula):

In neonates and infants under 1 year, a weight-based sizing is used:

  • Infants \<1 kg (Preterm): 2.5 mm ETT
  • Infants 1-2 kg: 3 mm ETT
  • Infants 2-3 kg (Full Term): 3-3.5 mm ETT
  • Infants >3 kg (3 months to 1 year): 3.5-4 mm ETT

In Infants > 1 year, ETT size will be selected based on the standard formula: Cole's Formula for uncuffed ETT.

ETT ID (mm) = (Age/4) + 4.

Group B (Ultrasound Group):

During mask ventilation, a trained anesthesiologist will perform transverse subglottic diameter measurement using a high-frequency linear ultrasound probe (7-15 MHz). The patient will be positioned supine with mild neck extension. The probe will be placed transversely just below the thyroid cartilage to identify the subglottic airway at the level of the cricoid cartilage. The measured diameter (in mm) will be recorded and used to determine ETT size from the equation:

ETT ID (mm) = Subglottic diameter (mm) × 0.8 To confirm appropriate ETT sizing, all patients will be placed on pressure-controlled mechanical ventilation and a leak test will be performed in both groups. Start with pressure 20-25 cm H₂O, if there is resistance to ETT passage into the trachea or no audible leak or ventilator-detected leak when the lungs are inflated, the tube will be exchanged for one that is 0.5 mm smaller. If a leak is detected, decrease the pressure to 10 cm H₂O. If there's still a detected leak at 10 cm H₂O, the ETT will be exchanged for one that is 0.5 mm larger. If there's no leak at 10 cm H₂O then the ETT is optimal. Tube size will be considered optimal when a tracheal leak is not detected at an inflation pressure between 10-20 cm H₂O with uncuffed tubes.

02

Conditions studied

  • Endotracheal Tube Wrongly Placed During Anesthetic Procedure
03

In context

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 8 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Pediatric patients (3 months to 8 years)
  • Patients with single ventricle physiology
  • Scheduled for Glenn or Fontan surgery or cardiac catheterization
  • Patients with Glenn or Fontan shunt scheduled for surgery

Exclusion criteria

Exclusion Criteria:

  • Refusal of legal guardians
  • Emergency surgery
  • Patients with tracheostomy tubes
  • Recent or active upper respiratory tract infection
  • Airway anomalies (e.g. Pierre Robin, Treacher Collins)
  • ICU stay due to complications other than that of airway
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Age-Based Formula Group

    In neonates and infants under 1 year, a weight-based sizing is used: * Infants \<1 kg (Preterm): 2.5 mm ETT * Infants 1-2 kg: 3 mm ETT * Infants 2-3 kg (Full Term): 3 - 3.5 mm ETT * Infants \>3 kg (3 months to 1 year): 3.5 - 4 mm ETT In Infants \> 1 year, ETT size will be selected based on the standard formula: Cole's Formula for uncuffed ETT. ETT ID (mm) = (Age/4) + 4.

    Other: Cole's Formula

  • Active comparator
    Ultrasound Group

    During mask ventilation, a trained anesthesiologist will perform transverse subglottic diameter measurement using a high-frequency linear ultrasound probe (7-15 MHz). The patient will be positioned supine with mild neck extension. The probe will be placed transversely just below the thyroid cartilage to identify the subglottic airway at the level of the cricoid cartilage. The measured diameter (in mm) will be recorded and used to determine ETT size from the equation: ETT ID (mm) = Subglottic diameter (mm) × 0.8

    Device: Ultrasound

Interventions

  • DeviceUltrasound

    Using Ultrasound for accuracy of ETT sizing

  • OtherCole's Formula

    Subglottic diameter in mm x 0.8

06

What researchers measure

Primary outcomes

  1. Accuracy of ETT size selection

    Accuracy of endotracheal tube size selection measured by the number of ETT attempts required to achieve an appropriate leak test and successful airway placement.

    Time frame: During endotracheal intubation, immediately after induction of anesthesia and neuromuscular blockade (within 10 minutes after induction)

Secondary outcomes

  1. Incidence of post-extubation stridor/croup

    Occurrence of post-extubation stridor or croup assessed using the Westley croup score.

    Time frame: From extubation until 24 hours post-extubation

  2. Severity of post-extubation croup

    Severity of post-extubation croup assessed using the Westley croup score

    Time frame: At 30 minutes, 2 hours, and 24 hours after extubation

  3. Duration of ICU stay related to airway complications

    Length of ICU stay due to airway complications such as post-extubation stridor

    Time frame: From ICU admission until ICU discharge, up to 30 days

07

Study locations

1 of 1 sites recruiting
  • Ain Shams University
    Cairo, Abbasseya 00202, Egypt
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07586592
Lead sponsor
Ain Shams University
Responsible party
Sponsor
First posted
May 14, 2026
Start date
Jan 1, 2026
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
May 14, 2026

Study contacts

Nouran Nemr, M.B.B.Ch, M.Sc.
Contact
Nourannemr@med.asu.edu.eg
01008558583
Mohamed Tolba, MD
Contact
01156622298

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion